Aspirin has been taken by millions, in the hopes that it will reduce the risk of heart disease and cancer. But new research says otherwise. A new control trial's results were released in the New England Journal of Medicine and the results show that an Aspirin a day doesn't actually keep the doctor away. Taken by people 65 years old or older, it increases the risk of death by cancer and it does not reduce the chance of them getting heart disease and dementia. This trial was led by John Mickey and involved more than 19,000 participants mostly over the age of 70. This was conducted in the United States of America and Australia. For the experiment, half the participants took a low dose of aspirin (100 milligrams of Aspirin ) and the other half took a placebo. Placebos are substances that are made to resemble drugs but do not contain an active drug. A placebo is made to look exactly like a real drug but is made of an inactive substance, such as a starch or sugar. This trial went on for 5 years and the researchers compared how the two groups were when it came to cardiovascular diseases, hemorrhages, cancer, dementia, disability, and overall mortality. The results were striking: “If you are healthy, there seems little to gain — and a fair amount to lose” from taking aspirin, as Yale cardiologist Harlan Krumholz said. Aspirin-taking women are likely to experience major bleeding and die from cancer and have a higher overall death rate. For heart disease, disability and dementia, taking an Aspirin didn't reduce the risk at all. The research saw no benefits of taking aspirin just a lot of potential harm. Now aspirin is only recommended for people between the ages 52-59 at the risk of cardiovascular disease for daily dosage.Aspirin has been taken by millions, in the hopes that it will reduce the risk of heart disease and cancer. But new research says otherwise. A new control trial's results were released in the New England Journal of Medicine and the results show that an Aspirin a day doesn't actually keep the doctor away. Taken by people 65 years old or older, it increases the risk of death by cancer and it does not reduce the chance of them getting heart disease and dementia. This trial was led by John Mickey and involved more than 19,000 participants mostly over the age of 70. This was conducted in the United States of America and Australia. For the experiment, half the participants took a low dose of aspirin (100 milligrams of Aspirin ) and the other half took a placebo. Placebos are substances that are made to resemble drugs but do not contain an active drug. A placebo is made to look exactly like a real drug but is made of an inactive substance, such as a starch or sugar. This trial went on for 5 years and the researchers compared how the two groups were when it came to cardiovascular diseases, hemorrhages, cancer, dementia, disability, and overall mortality. The results were striking: “If you are healthy, there seems little to gain — and a fair amount to lose” from taking aspirin, as Yale cardiologist Harlan Krumholz said. Aspirin-taking women are likely to experience major bleeding and die from cancer and have a higher overall death rate. For heart disease, disability and dementia, taking an Aspirin didn't reduce the risk at all. The research saw no benefits of taking aspirin just a lot of potential harm. Now aspirin is only recommended for people between the ages 52-59 at the risk of cardiovascular disease for daily dosage.
This comment has been removed by the author.
ReplyDelete